Cart (0)
  • No items in cart.
Total
$0
There is a technical issue about last added item. You can click "Report to us" button to let us know and we resolve the issue and return back to you or you can continue without last item via click to continue button.
Filters:
EDITION
to
PUBLISHER
(1)
(343)
(623)
(599)
(55)
(234)
(1019)
(696)
(2187)
(117)
(95582)
(63)
(590)
(124)
(33)
(24)
(20)
(96542)
(17)
(1)
(374)
(325)
(7302)
(241)
(21)
(7)
(1669)
(18)
(19)
(28)
(4)
 
(6)
(7)
(115)
(1)
(3)
(57)
(5)
(5)
(1)
(1)
(2)
(28)
(27)
(30)
(13)
(61)
(24)
(22)
(7)
(8)
(20)
(1)
(3)
(50)
(6)
(33)
CONTENT TYPE
 Act
 Admin Code
 Announcements
 Bill
 Book
 CADD File
 CAN
 CEU
 Charter
 Checklist
 City Code
 Code
 Commentary
 Comprehensive Plan
 Conference Paper
 County Code
 Course
 DHS Documents
 Document
 Errata
 Executive Regulation
 Federal Guideline
 Firm Content
 Guideline
 Handbook
 Interpretation
 Journal
 Land Use and Development
 Law
 Legislative Rule
 Local Amendment
 Local Code
 Local Document
 Local Regulation
 Local Standards
 Manual
 Model Code
 Model Standard
 Notice
 Ordinance
 Other
 Paperback
 PASS
 Periodicals
 PIN
 Plan
 Policy
 Product
 Product - Data Sheet
 Program
 Provisions
 Requirements
 Revisions
 Rules & Regulations
 Standards
 State Amendment
 State Code
 State Manual
 State Plan
 State Standards
 Statute
 Study Guide
 Supplement
 Sustainability
 Technical Bulletin
 All
  • ASTM
    F1984-25 Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials (Redline)
    Edition: 2025
    $144.00
    Unlimited Users per year

Description of ASTM-F1984 2025

ASTM F1984-25

Redline Standard: Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials




ASTM F1984

Scope

1.1 This practice provides a protocol for rapid, in vitro screening for whole complement activating properties of solid materials used in the fabrication of medical devices that will contact blood.

1.2 This practice is intended to evaluate the acute in vitro whole complement activating properties of solid materials intended for use in contact with blood. For this practice, the words “serum” and “complement” are used interchangeably (most biological supply houses use these words synonymously in reference to serum used as a source of complement).

1.3 This practice consists of two procedural parts. Procedure A describes exposure of solid materials to a standard lot of human serum, using a 0.1 mL serum/13 x 100 mm disposable test tube. Cellulose acetate powders and fibers are used as examples of test materials. Procedure B describes assaying the exposed serum for significant functional whole complement depletion as compared to control samples.

1.4 This practice does not address function, elaboration, or depletion of individual complement components, nor does it address the use of plasma as a source of complement.

1.5 This practice is one of several developed for the assessment of the biocompatibility of materials. Practice F748 may provide guidance for the selection of appropriate methods for testing materials for other aspects of biocompatibility.

1.6 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

1.7 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.


Keywords

biocompatibility; blood compatibility; whole complement testing;


ICS Code

ICS Number Code 11.100.30 (Analysis of blood and urine)


DOI: 10.1520/F1984-25



GROUPS